Academic Bibliography

Mark

Core outcome sets in dermatology : report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative

Jan Kottner (UGent) , L Jacobi, E Hahnel, M Alam, K Balzer, Dimitri Beeckman (UGent) , C Busard, J Chalmers, S Deckert, V Eleftheriadou, et al.

(2018) BRITISH JOURNAL OF DERMATOLOGY.

Mark

journalArticle

Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis

Nanja van Geel (UGent) , D Vandendriessche, E Vandersichel, S De Schepper, Lynda Grine (UGent) , L Mertens, V Vandaele, F Spoelders, M Bekkenk, A Wolkerstorfer, et al.

(2018) British Journal of Dermatology.

Mark

Towards an international language for incontinence-associated dermatitis (IAD) : design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries

Dimitri Beeckman (UGent) , Karen Van den Bussche (UGent) , Paulo Alves, Mary C Arnold Long, Hilde Beele (UGent) , Guido Ciprandi, Fiona Coyer, Tonny de Groot, Dorien De Meyer (UGent) , Ellen Deschepper (UGent) , et al.

(2018) BRITISH JOURNAL OF DERMATOLOGY. 178(6). p.1331-1340

Mark

misc

Vitiligo and lupus : more similarities than meets the eye

Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2017) BRITISH JOURNAL OF DERMATOLOGY. 177(5). p.1161-1162

Mark

journalArticle
A1
open access

Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice'

Lynda Grine (UGent) , Claude Libert (UGent) and Roosmarijn Vandenbroucke (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 174(6). p.1419-1419

Mark

journalArticle
A1
open access

Increased epidermal thickness and abnormal epidermal differentiation in keloid scars

GC Limandjaja, L van den Broek, T Waaijman, HA van Veen, V Everts, Stan Monstrey (UGent) , RJ Scheper, FB Niessen and S Gibbs

(2016) BRITISH JOURNAL OF DERMATOLOGY. 176(1). p.116-126

Mark

Chemoprevention of basal cell carcinoma : reply from authors

Isabelle Hoorens (UGent) and Lieve Brochez (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 175(6). p.1404-1405

Mark

Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread

Isabelle Hoorens (UGent) , ANNELEEN BATTEAUW (UGent) , GEORGES VAN MAELE (UGent) , K Lapiere, Barbara Boone (UGent) and Katia Ongenae (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 174(4). p.847-852

Mark

The many faces of IL-17 in inflammatory skin diseases

Reinhart Speeckaert (UGent) , Jo Lambert (UGent) , Lynda Grine (UGent) , Mireille Van Gele (UGent) , Sofie De Schepper (UGent) and Nanja van Geel (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 175(5). p.892-901

Mark

Cessation of spread as a treatment objective in vitiligo : perception from the patients' point of view

Nanja van Geel (UGent) , Valérie Desmedt (UGent) , Sofie De Schepper (UGent) , Barbara Boone (UGent) , Hilde Lapeere (UGent) and Reinhart Speeckaert (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 174(4). p.922-924

Academic Bibliography

Core outcome sets in dermatology : report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative

Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis

Towards an international language for incontinence-associated dermatitis (IAD) : design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries

Vitiligo and lupus : more similarities than meets the eye

Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice'

Increased epidermal thickness and abnormal epidermal differentiation in keloid scars

Chemoprevention of basal cell carcinoma : reply from authors

Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread

The many faces of IL-17 in inflammatory skin diseases

Cessation of spread as a treatment objective in vitiligo : perception from the patients' point of view

Contents

Support

Contact